Home/Protocols/Thymosin Alpha-1
Protocol Reference
Human trial data

Thymosin Alpha-1 protocol

Thymosin Alpha-1 (thymalfasin). Dosing on this page comes from a published human trial or an approved product label, cited below.

Category
Immune & Thymic
Common vials
10 mg
Half-life
~2 hours
Route in the literature
Subcutaneous
Evidence level
Human trial data

How Thymosin Alpha-1 works

A 28-amino-acid peptide originally isolated from thymic tissue. It acts on Toll-like receptors and promotes T-cell maturation and dendritic-cell function, which is why it is studied as an immune modulator rather than a stimulant.

Thymosin Alpha-1 dosing schedule

From the approved label. Thymalfasin is marketed as Zadaxin and approved in around thirty countries for chronic hepatitis B and as a vaccine adjuvant, though it is not FDA-approved in the United States. This is one of the few compounds in this category with a real regulatory dossier behind it.

PhaseAmountFrequencyNotes
Approved use1.6 mgTwice weekly, subcutaneousThe labelled amount and frequency for chronic hepatitis B.

Study length: Six months in the chronic hepatitis B indication.

Source for this schedule: Thymalfasin (Zadaxin) prescribing information, chronic hepatitis B indication. This reproduces what was administered in that work. It is reference information about a study, not a recommendation, and the trial population, monitoring and endpoints are part of what made it a protocol.

Reconstitution and measurement

This part is arithmetic and does not depend on the evidence level. Concentration is vial size divided by the bacteriostatic water you add. Draw volume is your target amount divided by that concentration. Units are draw volume times 100, because a U-100 syringe reads 100 units per millilitre. Common vials for Thymosin Alpha-1: 10 mg.

Open the Thymosin Alpha-1 calculator → Unit converter

Storage and stability

Dry powder
Cold, dark and dry. Lyophilized peptide is the stable form — keep it that way until you intend to use it.
After reconstitution
Refrigerate at 2–8 °C, protect from light, and plan around a limited window. Do not freeze a reconstituted vial — freeze-thaw damages peptides.
Mixing
Run bacteriostatic water down the inside wall of the vial rather than onto the powder, then swirl. Never shake.
Inspect before use
A clear solution is expected. Cloudiness or particles mean discard, not use.

Full storage guide → · Cloudy solution?

Reported effects

  • The label describes it as well tolerated, with injection-site discomfort the most common complaint.
  • Because it modulates rather than broadly stimulates immune function, it has also been studied in sepsis and in oncology adjunct settings.
  • Not FDA-approved in the United States, which is worth knowing given how it is often described.

Sourcing Thymosin Alpha-1

Whatever you are working with, the documentation matters more than the price. Ask for a batch certificate of analysis whose lot number matches the vial you actually receive — a COA for a different batch tells you nothing about yours.

Thymosin Alpha-1 at Summit Research Supply → Grade a COA first

Summit is the supplier we feature and an affiliate link. Our COA checklist applies the same way to any vendor.

Sources and further reading

For laboratory research use only. This page documents what the published literature reports about Thymosin Alpha-1. It is not a recommendation, not a treatment plan, and not medical advice. Compounds referenced are sold strictly as research chemicals and are not for human or veterinary use. Some supplier links are affiliate links and may earn us a commission. This never affects tier placement or review conclusions.
Summit Research Supply
Summit Research Supply — COA-verified research peptidesThird-party tested · U.S. fulfillment · new researchers save 10%
Shop →